Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Early notable gainers among liquid option names on April 15th » 09:55
04/15/21
04/15
09:55
04/15/21
09:55
NVDA

Nvidia

$638.50 /

+27.95 (+4.58%)

, UNH

UnitedHealth

$388.16 /

+12.41 (+3.30%)

, PGR

Progressive

$99.39 /

+2.17 (+2.23%)

, REGN

Regeneron

$493.50 /

+12.82 (+2.67%)

, PYPL

PayPal

$274.92 /

+7.48 (+2.80%)

Notable gainers among…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$638.50 /

+27.95 (+4.58%)

UNH UnitedHealth
$388.16 /

+12.41 (+3.30%)

PGR Progressive
$99.39 /

+2.17 (+2.23%)

REGN Regeneron
$493.50 /

+12.82 (+2.67%)

PYPL PayPal
$274.92 /

+7.48 (+2.80%)

NVDA Nvidia
$638.50 /

+27.95 (+4.58%)

07:25 Today Raymond James
Nvidia upgraded to Strong Buy from Outperform at Raymond James
07:00 Today Raymond James
Nvidia upgraded to Strong Buy from Outperform at Raymond James
04/14/21 Jefferies
Jefferies says Nvidia DC CPU launch, partnerships support earnings power thesis
04/13/21 Wells Fargo
Nvidia price target raised to $715 from $625 at Wells Fargo
UNH UnitedHealth
$388.16 /

+12.41 (+3.30%)

04/14/21 Truist
UnitedHealth price target raised to $450 from $420 at Truist
04/09/21 Mizuho
UnitedHealth price target raised to $394 from $380 at Mizuho
03/17/21 Stephens
Amazon news latest sign of rising telehealth competition, says Stephens
01/28/21 Stephens
Anthem price target lowered to $340 from $350 at Stephens
PGR Progressive
$99.39 /

+2.17 (+2.23%)

03/18/21 Edward Jones
Progressive upgraded to Buy from Hold at Edward Jones
03/09/21 BofA
BofA starts Root at Underperform with $9 price target
02/01/21 Deutsche Bank
Progressive price target lowered to $105 from $108 at Deutsche Bank
01/13/21 Gordon Haskett
Allstate lowering auto rates by 5% in several states, says Gordon Haskett
REGN Regeneron
$493.50 /

+12.82 (+2.67%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
03/24/21 Canaccord
Regeneron trial shows positive results against COVID-variants, says Canaccord
03/23/21 Piper Sandler
Regeneron lower dose cocktail likely to be added to EUA, says Piper Sandler
03/11/21 Evercore ISI
Kodiak Sciences initiated with an Outperform at Evercore ISI
PYPL PayPal
$274.92 /

+7.48 (+2.80%)

04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Oddo BHF
PayPal initiated with an Outperform at Oddo BHF
03/19/21 Susquehanna
PayPal chances of crypto success likely, says Susquehanna
03/12/21
Fly Intel: Top five analyst initiations
NVDA Nvidia
$638.50 /

+27.95 (+4.58%)

UNH UnitedHealth
$388.16 /

+12.41 (+3.30%)

PGR Progressive
$99.39 /

+2.17 (+2.23%)

REGN Regeneron
$493.50 /

+12.82 (+2.67%)

PYPL PayPal
$274.92 /

+7.48 (+2.80%)

  • 27
    May
NVDA Nvidia
$638.50 /

+27.95 (+4.58%)

UNH UnitedHealth
$388.16 /

+12.41 (+3.30%)

REGN Regeneron
$493.50 /

+12.82 (+2.67%)

PYPL PayPal
$274.92 /

+7.48 (+2.80%)

NVDA Nvidia
$638.50 /

+27.95 (+4.58%)

UNH UnitedHealth
$388.16 /

+12.41 (+3.30%)

REGN Regeneron
$493.50 /

+12.82 (+2.67%)

PYPL PayPal
$274.92 /

+7.48 (+2.80%)

NVDA Nvidia
$638.50 /

+27.95 (+4.58%)

UNH UnitedHealth
$388.16 /

+12.41 (+3.30%)

PGR Progressive
$99.39 /

+2.17 (+2.23%)

REGN Regeneron
$493.50 /

+12.82 (+2.67%)

PYPL PayPal
$274.92 /

+7.48 (+2.80%)

Hot Stocks
GlaxoSmithKline, Vir Biotechnology announce EMA review of VIR-7831 » 09:54
04/15/21
04/15
09:54
04/15/21
09:54
GSK

GlaxoSmithKline

$38.02 /

+1.895 (+5.25%)

, VIR

Vir Biotechnology

$45.02 /

-0.36 (-0.79%)

GlaxoSmithKline (GSK) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$38.02 /

+1.895 (+5.25%)

VIR Vir Biotechnology
$45.02 /

-0.36 (-0.79%)

GSK GlaxoSmithKline
$38.02 /

+1.895 (+5.25%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
GlaxoSmithKline downgraded to Market Perform from Outperform at SVB Leerink
03/08/21 JPMorgan
JPMorgan double downgrades AnaptysBio back to Underweight after trial miss
VIR Vir Biotechnology
$45.02 /

-0.36 (-0.79%)

03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
03/08/21 H.C. Wainwright
Vir Biotechnology price target raised to $135 from $125 at H.C. Wainwright
03/03/21 Goldman Sachs
Vir Biotechnology price target lowered to $59 from $61 at Goldman Sachs
03/03/21 H.C. Wainwright
Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright
GSK GlaxoSmithKline
$38.02 /

+1.895 (+5.25%)

VIR Vir Biotechnology
$45.02 /

-0.36 (-0.79%)

  • 08
    Jul
GSK GlaxoSmithKline
$38.02 /

+1.895 (+5.25%)

GSK GlaxoSmithKline
$38.02 /

+1.895 (+5.25%)

VIR Vir Biotechnology
$45.02 /

-0.36 (-0.79%)

GSK GlaxoSmithKline
$38.02 /

+1.895 (+5.25%)

Initiation
Fly Intel: Top five analyst initiations » 09:53
04/15/21
04/15
09:53
04/15/21
09:53
COIN

Coinbase

$335.00 /

+6.95 (+2.12%)

, AMD

AMD

$80.95 /

+2.41 (+3.07%)

, CRWD

Crowdstrike

$213.41 /

+5.19 (+2.49%)

, XGN

Exagen

$17.42 /

+0.55 (+3.26%)

, VC

Visteon

$119.19 /

+0.07 (+0.06%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Coinbase (COIN) initiated with a Buy at BTIG. 2. AMD (AMD) initiated with an Outperform at Raymond James. 3. Crowdstrike (CRWD) initiated with a Buy at Deutsche Bank. 4. Exagen (XGN) initiated with a Buy at Canaccord. 5. Visteon (VC) initiated with a Sector Weight at KeyBanc. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
COIN Coinbase
$335.00 /

+6.95 (+2.12%)

AMD AMD
$80.95 /

+2.41 (+3.07%)

CRWD Crowdstrike
$213.41 /

+5.19 (+2.49%)

XGN Exagen
$17.42 /

+0.55 (+3.26%)

VC Visteon
$119.19 /

+0.07 (+0.06%)

COIN Coinbase
$335.00 /

+6.95 (+2.12%)

08:25 Today DA Davidson
Coinbase price target raised to $650 from $440 at DA Davidson
05:33 Today BTIG
Coinbase initiated with a Buy at BTIG
04/13/21
Fly Intel: Top five analyst initiations
04/13/21 MoffettNathanson
Coinbase initiated with a Buy at MoffettNathanson
AMD AMD
$80.95 /

+2.41 (+3.07%)

07:21 Today Raymond James
AMD initiated with an Outperform at Raymond James
06:58 Today Raymond James
AMD initiated with an Outperform at Raymond James
04/12/21 Lynx
Intel, AMD selloffs on Nvidia 'Grace' news a buying opportunity, says Lynx
04/06/21 Raymond James
Performance gap between Intel, AMD 'remains massive,' says Raymond James
CRWD Crowdstrike
$213.41 /

+5.19 (+2.49%)

06:22 Today Deutsche Bank
Deutsche starts Crowdstrike with Buy rating, $265 price target
06:18 Today Deutsche Bank
Crowdstrike initiated with a Buy at Deutsche Bank
04/09/21 JPMorgan
Crowdstrike price target raised to $210 from $205 at JPMorgan
04/09/21 JMP Securities
Crowdstrike price target lowered to $265 from $295 at JMP Securities
XGN Exagen
$17.42 /

+0.55 (+3.26%)

07:32 Today Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
06:05 Today Canaccord
Exagen initiated with a Buy at Canaccord
03/17/21 Cowen
Exagen price target raised to $26 from $21 at Cowen
12/29/20 Cantor Fitzgerald
Exagen amended Janssen terms removes uncertainty, says Cantor Fitzgerald
VC Visteon
$119.19 /

+0.07 (+0.06%)

08:51 Today Barclays
Barclays shuffles ratings in Auto Parts into 'summer recovery'
08:28 Today Barclays
Visteon downgraded to Equal Weight from Overweight at Barclays
08:11 Today KeyBanc
Visteon initiated with a Sector Weight at KeyBanc on chip shortage exposure
04/14/21 KeyBanc
Visteon initiated with a Sector Weight at KeyBanc
COIN Coinbase
$335.00 /

+6.95 (+2.12%)

AMD AMD
$80.95 /

+2.41 (+3.07%)

CRWD Crowdstrike
$213.41 /

+5.19 (+2.49%)

XGN Exagen
$17.42 /

+0.55 (+3.26%)

VC Visteon
$119.19 /

+0.07 (+0.06%)

  • 14
    Apr
  • 23
    Mar
  • 26
    Jun
COIN Coinbase
$335.00 /

+6.95 (+2.12%)

AMD AMD
$80.95 /

+2.41 (+3.07%)

CRWD Crowdstrike
$213.41 /

+5.19 (+2.49%)

COIN Coinbase
$335.00 /

+6.95 (+2.12%)

AMD AMD
$80.95 /

+2.41 (+3.07%)

CRWD Crowdstrike
$213.41 /

+5.19 (+2.49%)

XGN Exagen
$17.42 /

+0.55 (+3.26%)

AMD AMD
$80.95 /

+2.41 (+3.07%)

CRWD Crowdstrike
$213.41 /

+5.19 (+2.49%)

Options
Unusually active option classes on open April 15th » 09:40
04/15/21
04/15
09:40
04/15/21
09:40
HPE

HP Enterprise

$15.78 /

+ (+0.00%)

, GSK

GlaxoSmithKline

$36.12 /

+ (+0.00%)

, INO

Inovio

$8.85 /

+ (+0.00%)

, MLCO

Melco Resorts & Entertainment

$19.53 /

+ (+0.00%)

, BX

Blackstone

$78.01 /

+ (+0.00%)

, SPCE

Virgin Galactic

$26.65 /

+ (+0.00%)

, TSM

TSMC

$120.87 /

+ (+0.00%)

, AI

C3.ai

$68.41 /

-0.07 (-0.10%)

, V

Visa

$222.14 /

+ (+0.00%)

, DOCU

DocuSign

$225.45 /

+ (+0.00%)

Unusual total active…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$15.78 /

+ (+0.00%)

GSK GlaxoSmithKline
$36.12 /

+ (+0.00%)

INO Inovio
$8.85 /

+ (+0.00%)

MLCO Melco Resorts & Entertainment
$19.53 /

+ (+0.00%)

BX Blackstone
$78.01 /

+ (+0.00%)

SPCE Virgin Galactic
$26.65 /

+ (+0.00%)

TSM TSMC
$120.87 /

+ (+0.00%)

AI C3.ai
$68.41 /

-0.07 (-0.10%)

V Visa
$222.14 /

+ (+0.00%)

DOCU DocuSign
$225.45 /

+ (+0.00%)

HPE HP Enterprise
$15.78 /

+ (+0.00%)

04/08/21 Morgan Stanley
HP Enterprise price target raised to $17 from $15.50 at Morgan Stanley
03/26/21 JPMorgan
HP Enterprise price target raised to $18 from $17 at JPMorgan
03/10/21
Fly Intel: Top five analyst upgrades
03/10/21 Daiwa
HP Enterprise upgraded to Outperform from Neutral at Daiwa
GSK GlaxoSmithKline
$36.12 /

+ (+0.00%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
GlaxoSmithKline downgraded to Market Perform from Outperform at SVB Leerink
03/08/21 JPMorgan
JPMorgan double downgrades AnaptysBio back to Underweight after trial miss
INO Inovio
$8.85 /

+ (+0.00%)

03/23/21
Fly Intel: Top five analyst initiations
03/23/21 BofA
Inovio initiated with a Neutral at BofA
03/02/21 Piper Sandler
Piper lowers Inovio target to $7 after 'decidedly negative' update
02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
MLCO Melco Resorts & Entertainment
$19.53 /

+ (+0.00%)

02/25/21 CLSA
Melco Resorts & Entertainment upgraded to Outperform from Underperform at CLSA
01/07/21 Macquarie
Melco Resorts & Entertainment downgraded to Neutral from Outperform at Macquarie
11/17/20 JPMorgan
Melco Resorts & Entertainment price target raised to $25 from $23 at JPMorgan
11/05/20 Roth Capital
Roth Capital trims price target on 'go-to Macau name' Melco Resorts to $30
BX Blackstone
$78.01 /

+ (+0.00%)

04/12/21 Barclays
Blackstone price target raised to $85 from $75 at Barclays
04/09/21 Deutsche Bank
Blackstone price target raised to $66 from $61 at Deutsche Bank
03/19/21
Fly Intel: Top five analyst downgrades
03/18/21 Oppenheimer
Blackstone downgraded to Perform on valuation at Oppenheimer
SPCE Virgin Galactic
$26.65 /

+ (+0.00%)

04/12/21 Bernstein
Virgin Galactic initiated with a Market Perform at Bernstein
03/16/21 Truist
Truist starts 'uniquely positioned' Virgin Galactic at Buy with $50 price target
03/16/21 Truist
Virgin Galactic initiated with a Buy at Truist
03/03/21 BofA
Virgin Galactic price target raised to $50 from $35 at BofA
TSM TSMC
$120.87 /

+ (+0.00%)

04/12/21
Fly Intel: Top five analyst initiations
04/12/21 Atlantic Equities
TSMC initiated with a Neutral at Atlantic Equities
04/01/21 DA Davidson
Onto Innovation price target raised to $80 from $75 at DA Davidson
03/29/21 Citi
TSMC recent selloff brings 'enhanced buying opportunity,' says Citi
AI C3.ai
$68.41 /

-0.07 (-0.10%)

03/02/21 Canaccord
C3.ai price target lowered to $120 from $140 at Canaccord
01/04/21 KeyBanc
C3.ai initiated with a Sector Weight at KeyBanc
01/04/21 Wedbush
Wedbush bullish on C3.ai, initiates with an Outperform
01/04/21 Canaccord
C3.ai initiated with a Hold at Canaccord
V Visa
$222.14 /

+ (+0.00%)

03/19/21 JPMorgan
Visa has 'navigated heavy regulatory oversight' before, says JPMorgan
03/19/21 Wells Fargo
Visa selloff on WSJ story likely a buying opportunity, says Wells Fargo
03/19/21 Barclays
Visa, MasterCard facing new DOJ scrutiny on debt practices, says Barclays
03/16/21 Morgan Stanley
Visa price target raised to $253 from $233 at Morgan Stanley
DOCU DocuSign
$225.45 /

+ (+0.00%)

04/08/21 BofA
BofA reinstates DocuSign at Buy with $250 price target
04/08/21 BofA
DocuSign reinstated with a Buy at BofA
03/29/21 Daiwa
DocuSign initiated with a Buy at Daiwa
03/25/21 DA Davidson
DocuSign still confident in reaching $5B or more in revenue, says DA Davidson
HPE HP Enterprise
$15.78 /

+ (+0.00%)

GSK GlaxoSmithKline
$36.12 /

+ (+0.00%)

INO Inovio
$8.85 /

+ (+0.00%)

MLCO Melco Resorts & Entertainment
$19.53 /

+ (+0.00%)

BX Blackstone
$78.01 /

+ (+0.00%)

SPCE Virgin Galactic
$26.65 /

+ (+0.00%)

TSM TSMC
$120.87 /

+ (+0.00%)

AI C3.ai
$68.41 /

-0.07 (-0.10%)

V Visa
$222.14 /

+ (+0.00%)

DOCU DocuSign
$225.45 /

+ (+0.00%)

  • 21
    Jan
  • 09
    Dec
  • 13
    Oct
  • 06
    Aug
  • 03
    Jun
  • 20
    May
GSK GlaxoSmithKline
$36.12 /

+ (+0.00%)

BX Blackstone
$78.01 /

+ (+0.00%)

SPCE Virgin Galactic
$26.65 /

+ (+0.00%)

TSM TSMC
$120.87 /

+ (+0.00%)

V Visa
$222.14 /

+ (+0.00%)

DOCU DocuSign
$225.45 /

+ (+0.00%)

HPE HP Enterprise
$15.78 /

+ (+0.00%)

GSK GlaxoSmithKline
$36.12 /

+ (+0.00%)

INO Inovio
$8.85 /

+ (+0.00%)

MLCO Melco Resorts & Entertainment
$19.53 /

+ (+0.00%)

BX Blackstone
$78.01 /

+ (+0.00%)

SPCE Virgin Galactic
$26.65 /

+ (+0.00%)

TSM TSMC
$120.87 /

+ (+0.00%)

AI C3.ai
$68.41 /

-0.07 (-0.10%)

V Visa
$222.14 /

+ (+0.00%)

DOCU DocuSign
$225.45 /

+ (+0.00%)

HPE HP Enterprise
$15.78 /

+ (+0.00%)

INO Inovio
$8.85 /

+ (+0.00%)

MLCO Melco Resorts & Entertainment
$19.53 /

+ (+0.00%)

BX Blackstone
$78.01 /

+ (+0.00%)

SPCE Virgin Galactic
$26.65 /

+ (+0.00%)

TSM TSMC
$120.87 /

+ (+0.00%)

AI C3.ai
$68.41 /

-0.07 (-0.10%)

V Visa
$222.14 /

+ (+0.00%)

DOCU DocuSign
$225.45 /

+ (+0.00%)

Conference/Events
Canaccord to hold a virtual conference » 09:39
04/15/21
04/15
09:39
04/15/21
09:39
ONCY

Oncolytics

$3.06 /

-0.08 (-2.55%)

, SESN

Sesen Bio

$2.35 /

+0.015 (+0.64%)

, OLMA

Olema Oncology

$35.84 /

+3.56 (+11.03%)

, SQZ

SQZ Biotechnologies

$13.06 /

-0.12 (-0.91%)

, APTO

Aptose Biosciences

$5.20 /

+0.09 (+1.76%)

, BCEL

Atreca

$12.42 /

+0.83 (+7.16%)

, BNTX

BioNTech

$132.52 /

+3.11 (+2.40%)

Horizons in Oncology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

02/17/21 H.C. Wainwright
Oncolytics initiated with a Buy at H.C. Wainwright
05/11/20 RBC Capital
Oncolytics price target lowered to C$6 from C$9 at RBC Capital
SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
12/14/20 Canaccord
Olema Pharmaceuticals initiated with a Buy at Canaccord
12/14/20 Cowen
Olema Pharmaceuticals initiated with an Outperform at Cowen
SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
BCEL Atreca
$12.42 /

+0.83 (+7.16%)

02/08/21 Jefferies
Atreca initiated with a Buy at Jefferies
08/12/20 Stifel
Volatility in Atreca shares creates 'interesting' opportunity, says Stifel
07/08/20 Piper Sandler
Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler
07/01/20 Canaccord
Atreca price target raised to $33 from $23 at Canaccord
BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

BCEL Atreca
$12.42 /

+0.83 (+7.16%)

  • 12
    Feb
  • 19
    Nov
  • 30
    Oct
  • 23
    Jul
  • 16
    Jul
  • 16
    Jul
BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

Periodicals
Syneos could be CRO 'target still standing when music stops,' Dealreporter says » 09:29
04/15/21
04/15
09:29
04/15/21
09:29
SYNH

Syneos Health

$79.53 /

+0.68 (+0.86%)

, TMO

Thermo Fisher

$477.68 /

-7.13 (-1.47%)

, PPD

PPD

$42.65 /

+4.3 (+11.21%)

, ICLR

Icon

$196.37 /

-1.44 (-0.73%)

After Thermo Fisher (TMO)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYNH Syneos Health
$79.53 /

+0.68 (+0.86%)

TMO Thermo Fisher
$477.68 /

-7.13 (-1.47%)

PPD PPD
$42.65 /

+4.3 (+11.21%)

ICLR Icon
$196.37 /

-1.44 (-0.73%)

SYNH Syneos Health
$79.53 /

+0.68 (+0.86%)

03/02/21 Barclays
Syneos Health initiated with an Equal Weight at Barclays
03/02/21 Barclays
Syneos Health initiated with an Equal Weight at Barclays
02/22/21 Mizuho
Syneos Health price target raised to $87 from $72 at Mizuho
02/19/21 Citi
Syneos Health price target raised to $85 from $80 at Citi
TMO Thermo Fisher
$477.68 /

-7.13 (-1.47%)

06:53 Today Citi
Thermo Fisher deal for PPD would make sense, says Citi
03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
PPD PPD
$42.65 /

+4.3 (+11.21%)

09:17 Today Baird
PPD downgraded to Neutral from Outperform at Baird
06:53 Today Citi
Thermo Fisher deal for PPD would make sense, says Citi
03/02/21 Barclays
PPD initiated with an Overweight at Barclays
03/02/21 Barclays
PPD initiated with an Overweight at Barclays
ICLR Icon
$196.37 /

-1.44 (-0.73%)

04/13/21 BofA
Icon resumed with a Neutral at BofA
04/01/21 Wells Fargo
Icon upgraded to Overweight from Equal Weight at Wells Fargo
04/01/21 Wells Fargo
Icon upgraded to Overweight from Equal Weight at Wells Fargo
03/19/21 Mizuho
PRA Health price target raised to $155 from $110 at Mizuho
SYNH Syneos Health
$79.53 /

+0.68 (+0.86%)

TMO Thermo Fisher
$477.68 /

-7.13 (-1.47%)

PPD PPD
$42.65 /

+4.3 (+11.21%)

ICLR Icon
$196.37 /

-1.44 (-0.73%)

  • 01
    Mar
  • 02
    Dec
  • 17
    Sep
  • 16
    Sep
TMO Thermo Fisher
$477.68 /

-7.13 (-1.47%)

PPD PPD
$42.65 /

+4.3 (+11.21%)

TMO Thermo Fisher
$477.68 /

-7.13 (-1.47%)

PPD PPD
$42.65 /

+4.3 (+11.21%)

ICLR Icon
$196.37 /

-1.44 (-0.73%)

Hot Stocks
Xoma adds three Affimed ICE programs to royalty portfolio » 09:14
04/15/21
04/15
09:14
04/15/21
09:14
XOMA

Xoma

$37.39 /

-0.175 (-0.47%)

, AFMD

Affimed

$10.33 /

+0.465 (+4.71%)

XOMA Corporation (XOMA)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XOMA Xoma
$37.39 /

-0.175 (-0.47%)

AFMD Affimed
$10.33 /

+0.465 (+4.71%)

XOMA Xoma
$37.39 /

-0.175 (-0.47%)

01/19/21 H.C. Wainwright
Xoma price target raised to $56 from $30 at H.C. Wainwright
AFMD Affimed
$10.33 /

+0.465 (+4.71%)

04/12/21 BMO Capital
Affimed price target raised to $15 from $12 at BMO Capital
03/30/21 Credit Suisse
Affimed N.V. initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Affimed N.V. initiated with an Outperform at Credit Suisse
03/24/21 Wells Fargo
Affimed N.V. price target raised to $15 from $10 at Wells Fargo
XOMA Xoma
$37.39 /

-0.175 (-0.47%)

  • 13
    Jan
AFMD Affimed
$10.33 /

+0.465 (+4.71%)

Recommendations
Molecular Templates price target lowered to $13 from $18 at Oppenheimer » 08:22
04/15/21
04/15
08:22
04/15/21
08:22
MTEM

Molecular Templates

$8.24 /

+0.39 (+4.97%)

, TAK

Takeda Pharmaceutical

$17.06 /

+0.055 (+0.32%)

Oppenheimer analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTEM Molecular Templates
$8.24 /

+0.39 (+4.97%)

TAK Takeda Pharmaceutical
$17.06 /

+0.055 (+0.32%)

MTEM Molecular Templates
$8.24 /

+0.39 (+4.97%)

04/05/21 Jefferies
Jefferies views Molecular Templates selloff as overdone, boosts price target
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
02/01/21 UBS
Molecular Templates initiated with a Neutral at UBS
09/08/20 Jefferies
Molecular Templates initiated with a Buy at Jefferies
TAK Takeda Pharmaceutical
$17.06 /

+0.055 (+0.32%)

04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
04/05/21 Jefferies
Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies
03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
MTEM Molecular Templates
$8.24 /

+0.39 (+4.97%)

TAK Takeda Pharmaceutical
$17.06 /

+0.055 (+0.32%)

  • 18
    Feb
MTEM Molecular Templates
$8.24 /

+0.39 (+4.97%)

TAK Takeda Pharmaceutical
$17.06 /

+0.055 (+0.32%)

TAK Takeda Pharmaceutical
$17.06 /

+0.055 (+0.32%)

Hot Stocks
Adverum files definitive proxy materials, accelerates ADVM-022 commercialization » 08:18
04/15/21
04/15
08:18
04/15/21
08:18
ADVM

Adverum Biotechnologies

$9.14 /

+0.13 (+1.44%)

Adverum Biotechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$9.14 /

+0.13 (+1.44%)

ADVM Adverum Biotechnologies
$9.14 /

+0.13 (+1.44%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
ADVM Adverum Biotechnologies
$9.14 /

+0.13 (+1.44%)

  • 13
    Aug
Hot Stocks
Amyris to acquire EcoFabulous Cosmetics, terms not disclosed » 08:03
04/15/21
04/15
08:03
04/15/21
08:03
AMRS

Amyris

$16.07 /

+0.71 (+4.62%)

Amyris announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRS Amyris
$16.07 /

+0.71 (+4.62%)

AMRS Amyris
$16.07 /

+0.71 (+4.62%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$16.07 /

+0.71 (+4.62%)

  • 09
    Apr
AMRS Amyris
$16.07 /

+0.71 (+4.62%)

AMRS Amyris
$16.07 /

+0.71 (+4.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.